Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Higher-dose weight loss injections now available." A new study increases max-dose guidance for semaglutide. This offers hope for those who didn’t reach their weight goals. The Injection and ...

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

Inject semaglutide under your skin (avoiding muscles and veins) in fattier areas like your upper arm, stomach, or thigh. Rotating the injection site for each dose may help reduce your risk of skin ...

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for ...

Over the nine-week trial, participants taking semaglutide started at a dose of 0.25 mg per week, which gradually increased to 1.0 mg in the final week -- a much lower dose than what’s typically ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.

A recent study has found that the diabetes drug tirzepatide helps people with type 2 diabetes lower their blood sugar and ...